Page last updated: 2024-11-12

enerbol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Life: The state that distinguishes organisms from inorganic matter, manifested by growth, metabolism, reproduction, and adaptation. It includes the course of existence, the sum of experiences, the mode of existing, or the fact of being. Over the centuries inquiries into the nature of life have crossed the boundaries from philosophy to biology, forensic medicine, anthropology, etc., in creative as well as scientific literature. (Random House Unabridged Dictionary, 2d ed; Dr. James H. Cassedy, NLM History of Medicine Division) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12309456
MeSH IDM0018265

Synonyms (30)

Synonym
pyridoxin-5'-disulfid dihydrochlorid hydrat [german]
einecs 233-178-5
4-pyridinemethanol, 3,3'-(dithiodimethylene)bis(5-hydroxy-6-methyl-, dihydrochloride
nsc 526973
4-pyridinemethanol, 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-, dihydrochloride
pyritioxine hydrochloride
4-pyridinemethanol,3'-[dithiobis(methylene)]bis[5-hydroxy-6-methyl-, dihydrochloride
3,3'-dithiobis(methylene)bis(5-hydroxy-6-methyl-4-pyridinemethanol) dihydrochloride
dinerfene
enerbol
4-pyridinemethanol,3'-(dithiodimethylene)bis[5-hydroxy-6-methyl-, dihydrochloride
pyriditol
nsc-526973
life
nsc526973
unii-cfa914331m
cfa914331m ,
pyridoxin-5'-disulfid dihydrochlorid hydrat
4-pyridinemethanol, 3,3'-(dithiobis(methylene)bis(5-hydroxy-6-methyl-, hydrochloride
15784-05-1
pyrithinol hydrochloride
anhydrous pyritinol hydrochloride
5,5-dihydroxy-6,6-dimethyl-3,3-dithiodimethylenebis(4-pyridylmethanol) dihydochloride
pyritinol hydrochloride [who-dd]
4-pyridinemethanol, 3,3'-(dithiobis(methylene))bis(5-hydroxy-6-methyl-, hydrochloride (1:2)
anhydrous pyritinol hydrochloride [mart.]
pyritinol hydrochloride anhydrous
5-[[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methylpyridin-3-ol;hydrochloride
Q27275431
AKOS040744680

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" As a final remark, there are straightforward indications of a strong need for anti-Microbial-Induced-Corrosion commercial coatings to substitute the toxic compounds with others in order to develop a greener solution."( Biotoxicity and life cycle assessment of two commercial antifouling coatings in marine systems.
Matteucci, G; Napolano, L; Rossini, P, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The dose-response has taken center stage ever since its formulation by Paracelsus."( Quantitative definition of toxicity: a mathematical description of life and death with dose and time as variables.
Rozman, KK, 1998
)
0.3
", diversification and reasonable dosing of life's dimensions)."( Single, childless working women's construction of wellbeing: On balance, being dynamic and tensions between them.
Descarries, F; Engler, K; Fernet, M; Frohlich, K, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,246)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902599 (61.21)18.7374
1990's421 (9.92)18.2507
2000's520 (12.25)29.6817
2010's664 (15.64)24.3611
2020's42 (0.99)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.40 (24.57)
Research Supply Index8.46 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (0.15%)5.53%
Reviews222 (4.72%)6.00%
Case Studies46 (0.98%)4.05%
Observational0 (0.00%)0.25%
Other4,433 (94.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]